Immediate Impact
51 standout
Citing Papers
Bispecific antibodies: advancing precision oncology
2024 Standout
Latest advances in hepatocellular carcinoma management and prevention through advanced technologies
2024 Standout
Works of Ken Liao being referenced
Efficacy and safety of elranatamab (PF-06863135), a B-cell maturation antigen (BCMA)-CD3 bispecific antibody, in patients with relapsed or refractory multiple myeloma (MM).
2021
MicroRNA-7 inhibits hepatocellular carcinoma cell invasion and metastasis by regulating Atg5-mediated autophagy
2020
Author Peers
| Author | Last Decade | Papers | Cites | |||
|---|---|---|---|---|---|---|
| Ken Liao | 103 | 102 | 206 | 24 | 460 | |
| T B Starr | 212 | 242 | 186 | 13 | 567 | |
| Diane J. Abernethy | 168 | 243 | 163 | 24 | 458 | |
| Albrecht Poth | 155 | 181 | 152 | 19 | 416 | |
| Rudolf Jäckh | 111 | 135 | 217 | 24 | 496 | |
| James J. Freeman | 113 | 139 | 148 | 26 | 512 | |
| Nadia Quignot | 58 | 28 | 217 | 40 | 523 | |
| Gerard Bowe | 187 | 43 | 155 | 14 | 512 | |
| Louise Latriano | 162 | 246 | 161 | 21 | 523 | |
| Matthias Rinke | 92 | 75 | 71 | 28 | 490 | |
| Cristina Croera | 123 | 45 | 132 | 25 | 462 |
All Works
Login with ORCID to disown or claim papers
Loading papers...